Intoxicating Histories – serie

Despite having the highest rates of cannabis use in the continent, France enforces the most repressive laws against the drug in all of Europe. Perhaps surprisingly, France was once the epicentre of a global movement to medicalize cannabis, specifically hashish, in the treatment of disease. In Taming Cannabis David Guba examines how nineteenth-century French authorities routinely blamed hashish consumption, especially among Muslim North Africans, for behaviour deemed violent and threatening to the social order. This association of hashish with violence became the primary impetus for French pharmacists and physicians to tame the drug and deploy it in the homeopathic treatment of mental illness and epidemic disease during the 1830s and 1840s. Initially heralded as a wonder drug capable of curing insanity, cholera, and the plague, hashish was deemed ineffective against these diseases and fell out of repute by the middle 1850s. The association between hashish and Muslim violence, however, remained and became codified in French colonial medicine and law by the 1860s: authorities framed hashish as a significant cause of mental illness, violence, and anti-state resistance among indigenous Algerians. As the French government looks to reform the nation's drug laws to address the rise in drug-related incarceration and the growing popular demand for cannabis legalization, Taming Cannabis provides a timely and fascinating exploration of the largely untold and living history of cannabis in colonial France.

Despite having the highest rates of cannabis use in the continent, France enforces the most repressive laws against the drug in all of Europe. Perhaps surprisingly, France was once the epicentre of a global movement to medicalize cannabis, specifically hashish, in the treatment of disease. In Taming Cannabis David Guba examines how nineteenth-century French authorities routinely blamed hashish consumption, especially among Muslim North Africans, for behaviour deemed violent and threatening to the social order. This association of hashish with violence became the primary impetus for French pharmacists and physicians to tame the drug and deploy it in the homeopathic treatment of mental illness and epidemic disease during the 1830s and 1840s. Initially heralded as a wonder drug capable of curing insanity, cholera, and the plague, hashish was deemed ineffective against these diseases and fell out of repute by the middle 1850s. The association between hashish and Muslim violence, however, remained and became codified in French colonial medicine and law by the 1860s: authorities framed hashish as a significant cause of mental illness, violence, and anti-state resistance among indigenous Algerians. As the French government looks to reform the nation's drug laws to address the rise in drug-related incarceration and the growing popular demand for cannabis legalization, Taming Cannabis provides a timely and fascinating exploration of the largely untold and living history of cannabis in colonial France.

In the 1950s, the causal link between smoking and lung cancer surfaced in medical journals and mainstream media. Yet the best years for the Canadian cigarette industry were still to come, as per capita cigarette consumption rose steadily in the 1960s and 1970s. In Cigarette Nation, Daniel Robinson examines the vibrant and contentious history of smoking to discover why Canadians continued to light up despite the publicized health risks.Highlighting the prolific marketing and advertising practices that helped make smoking a staple of everyday life, Robinson explores socio-cultural aspects of cigarette use from the 1930s to the 1950s and recounts the views and actions of tobacco executives, government officials, and Canadian smokers as they responded to mounting evidence that cigarette use was harmful. The persistence of smoking owes to such factors as product development, marketing and retailing innovation, public relations, sponsored science, and government inaction. Domestic and international tobacco firms worked to furnish Canadian smokers with hope and doubt: hope in the form of reassuring marketing, as seen with light and mild cigarette brands, and doubt by means of disinformation campaigns attacking medical research and press accounts that aligned cigarettes with serious disease.Drawing on a wide range of primary sources, including thousands of industry records released during a landmark tobacco class-action trial in 2015, Cigarette Nation documents in rich detail the history of one of Canada’s foremost public health issues.

When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines.With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalizing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism.Remedicalizing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today's debates about cannabis.

In the nineteenth century, drug consumption permeated French society to produce a new norm: the chemical enhancement of modern life. French citizens empowered themselves by seeking pharmaceutical relief for their suffering and engaging in self-medication. Doctors and pharmacists, meanwhile, fashioned themselves as gatekeepers to these potent drugs, claiming that their expertise could shield the public from accidental harm. Despite these efforts, the unanticipated phenomenon of addiction laid bare both the embodied nature of the modern self and the inherent instability of the notions of individual free will and responsibility.Drugging France explores the history of mind-altering drugs in medical practice between 1840 and 1920, highlighting the intricate medical histories of opium, morphine, ether, chloroform, cocaine, and hashish. While most drug histories focus on how drugs became regulated and criminalized as dangerous addictive substances, Sara Black instead traces the spread of these drugs through French society, demonstrating how new therapeutic norms and practices of drug consumption transformed the lives of French citizens as they came to expect and even demand pharmaceutical solutions to their pain. Through self-experimentation, doctors developed new knowledge about these drugs, transforming exotic botanical substances and unpredictable chemicals into reliable pharmaceutical commodities that would act on the mind and body to modify pain, sensation, and consciousness.From the pharmacy counter to the boudoir, from the courtroom to the operating theatre, from the battlefield to the birthing chamber, Drugging France explores how everyday encounters with drugs reconfigured how people experienced their own minds and bodies.

In the nineteenth century, drug consumption permeated French society to produce a new norm: the chemical enhancement of modern life. French citizens empowered themselves by seeking pharmaceutical relief for their suffering and engaging in self-medication. Doctors and pharmacists, meanwhile, fashioned themselves as gatekeepers to these potent drugs, claiming that their expertise could shield the public from accidental harm. Despite these efforts, the unanticipated phenomenon of addiction laid bare both the embodied nature of the modern self and the inherent instability of the notions of individual free will and responsibility.Drugging France explores the history of mind-altering drugs in medical practice between 1840 and 1920, highlighting the intricate medical histories of opium, morphine, ether, chloroform, cocaine, and hashish. While most drug histories focus on how drugs became regulated and criminalized as dangerous addictive substances, Sara Black instead traces the spread of these drugs through French society, demonstrating how new therapeutic norms and practices of drug consumption transformed the lives of French citizens as they came to expect and even demand pharmaceutical solutions to their pain. Through self-experimentation, doctors developed new knowledge about these drugs, transforming exotic botanical substances and unpredictable chemicals into reliable pharmaceutical commodities that would act on the mind and body to modify pain, sensation, and consciousness.From the pharmacy counter to the boudoir, from the courtroom to the operating theatre, from the battlefield to the birthing chamber, Drugging France explores how everyday encounters with drugs reconfigured how people experienced their own minds and bodies.

Early modern Russians preferred one method of treating the sick above all others: prescribing drugs. The Moscow court sourced pharmaceuticals from Asia, Africa, Western Europe, and the Americas, in addition to its own sprawling empire, to heal its ailing tsars.Mixing Medicines explores the dynamic and complex world of early modern Russian medical drugs, from its enthusiasm for newly imported American botanicals to its disgust at Western European medicines made from human corpses. Clare Griffin draws from detailed apothecary records to shed light on the early modern Russian Empire’s role in the global trade in medical drugs. Chapters follow the trade and use of medical ingredients through networks that linked Moscow to Western Europe, Asia, and the Americas; the transformation of natural objects, such as botanicals and chemicals, into medicines; the documentation and translation of medical knowledge; and Western European influence on Russian medical practices. Looking beyond practitioners, texts, and ideas to consider how materials of medicine were used by one of the early modern world’s major empires provides a novel account of the global history of early modern medicine.Mixing Medicines offers unique insight into how the dramatic reshaping of global trade touched the day-to-day lives of the people living in early modern Russia.

Early modern Russians preferred one method of treating the sick above all others: prescribing drugs. The Moscow court sourced pharmaceuticals from Asia, Africa, Western Europe, and the Americas, in addition to its own sprawling empire, to heal its ailing tsars.Mixing Medicines explores the dynamic and complex world of early modern Russian medical drugs, from its enthusiasm for newly imported American botanicals to its disgust at Western European medicines made from human corpses. Clare Griffin draws from detailed apothecary records to shed light on the early modern Russian Empire's role in the global trade in medical drugs. Chapters follow the trade and use of medical ingredients through networks that linked Moscow to Western Europe, Asia, and the Americas; the transformation of natural objects, such as botanicals and chemicals, into medicines; the documentation and translation of medical knowledge; and Western European influence on Russian medical practices. Looking beyond practitioners, texts, and ideas to consider how materials of medicine were used by one of the early modern world's major empires provides a novel account of the global history of early modern medicine.Mixing Medicines offers unique insight into how the dramatic reshaping of global trade touched the day-to-day lives of the people living in early modern Russia.

As LSD moves towards the medical mainstream, it continues to evoke powerful memories of the psychedelic sixties and west coast counterculture. In this lively account, Chris Elcock follows a different branch of psychedelic history – one that is sprawling, layered, and centred on New York City. A major hub for the production and consumption of LSD and other hallucinogenic drugs, New York spawned a unique psychedelic culture that reverberated through the city, from psychoanalytic circles to artists’ studios, Greenwich Village to Central Park. Based on years of archival research, interviews with former acid heads, and a range of cultural artifacts, Psychedelic New York shows how the postwar city was at the forefront of LSD medical research, the burgeoning of psychedelic art, drug-accompanied spiritual seeking, and a proliferation of drug subcultures. Elcock recounts stories of New Yorkers such as Holocaust survivor Nina Graboi and artist Isaac Abrams, whose lives were dramatically altered by their psychedelic experiences, while offering new insights into Timothy Leary’s role in turning on the city with psilocybin.Enlivened by personal stories and rooted in thoughtful analysis, Psychedelic New York is a multifaceted history of LSD and the urban psychedelic experience.

As LSD moves towards the medical mainstream, it continues to evoke powerful memories of the psychedelic sixties and west coast counterculture. In this lively account, Chris Elcock follows a different branch of psychedelic history – one that is sprawling, layered, and centred on New York City. A major hub for the production and consumption of LSD and other hallucinogenic drugs, New York spawned a unique psychedelic culture that reverberated through the city, from psychoanalytic circles to artists’ studios, Greenwich Village to Central Park. Based on years of archival research, interviews with former acid heads, and a range of cultural artifacts, Psychedelic New York shows how the postwar city was at the forefront of LSD medical research, the burgeoning of psychedelic art, drug-accompanied spiritual seeking, and a proliferation of drug subcultures. Elcock recounts stories of New Yorkers such as Holocaust survivor Nina Graboi and artist Isaac Abrams, whose lives were dramatically altered by their psychedelic experiences, while offering new insights into Timothy Leary’s role in turning on the city with psilocybin.Enlivened by personal stories and rooted in thoughtful analysis, Psychedelic New York is a multifaceted history of LSD and the urban psychedelic experience.

At present India is a leading producer, distributor, and consumer of generic medicines globally. Disparate Remedies traces the genealogy of this development and examines the public cultures of medicine in the country between 1870 and 1960.The book begins by discussing the expansion of medical consumerism in late nineteenth-century India when British-owned firms extended their sales into remote towns. As a result, laboratory-produced drugs competed with traditional remedies through side-by-side production of Western and Indian drugs by pharmaceutical companies. The emergent middle classes, the creation of a public sphere, and nationalist politics transformed the medical culture of modern India and generated conflict between Western and Indigenous medical systems and their practitioners. Nandini Bhattacharya demonstrates that these disparate therapies were sustained through the tropes of purity or adulteration, potency or lack of it, and epistemic heritage, even when their material configuration often differed little.Uniquely engaging with the cultures of both consumption and production in the country, Disparate Remedies follows the evolution of medicine in colonial India as it confronted Indian modernity and changing public attitudes surrounding health and drugs.

At present India is a leading producer, distributor, and consumer of generic medicines globally. Disparate Remedies traces the genealogy of this development and examines the public cultures of medicine in the country between 1870 and 1960.The book begins by discussing the expansion of medical consumerism in late nineteenth-century India when British-owned firms extended their sales into remote towns. As a result, laboratory-produced drugs competed with traditional remedies through side-by-side production of Western and Indian drugs by pharmaceutical companies. The emergent middle classes, the creation of a public sphere, and nationalist politics transformed the medical culture of modern India and generated conflict between Western and Indigenous medical systems and their practitioners. Nandini Bhattacharya demonstrates that these disparate therapies were sustained through the tropes of purity or adulteration, potency or lack of it, and epistemic heritage, even when their material configuration often differed little.Uniquely engaging with the cultures of both consumption and production in the country, Disparate Remedies follows the evolution of medicine in colonial India as it confronted Indian modernity and changing public attitudes surrounding health and drugs.

Beginning in the fall of 1914, every French soldier on the Western Front received a daily ration of wine from the army. At first it was a modest quarter litre, but by 1917 it had increased to the equivalent of a full bottle each day. The wine ration was intended to sustain morale in the trenches, making the men more willing to endure suffering and boredom. The army also supplied soldiers with doses of distilled alcohol just before attacks to increase their ferocity and fearlessness. This strategic distribution of alcohol was a defining feature of French soldiers’ experiences of the war and amounted to an experimental policy of intoxicating soldiers for military ends.A Thirst for Wine and War explores the French army’s emotional and behavioural conditioning of soldiers through the distribution of a mind-altering drug that was later hailed as one of the army’s “fathers of victory.” The daily wine ration arose from an unexpected set of factors including the demoralization of trench warfare, the wine industry’s fear of losing its main consumers, and medical consensus about the benefits of wine drinking. The army’s related practice of distributing distilled alcohol to embolden soldiers was a double-edged sword, as the men might become unruly. The army implemented regulations and surveillance networks to curb men’s drinking behind the lines, in an attempt to ensure they only drank when it was useful to the war effort. When morale collapsed in spring 1917, the army lost control of this precarious system as drunken soldiers mutinied in the thousands. Discipline was restored only when the army regained command of soldiers’ alcohol consumption.Drawing on a range of archives, personal narratives, and trench journals, A Thirst for Wine and War shows how the French army’s intoxication of its soldiers constituted a unique exercise of biopower deployed on a mass scale.

The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain's imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.

The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain's imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.

The nineteenth-century spread of democracy in Britain and its colonies coincided with an increase in alcohol consumption and in celebratory public dinners with rounds of toasts. British colonists raised their glasses to salute the Crown in rituals that asserted fraternal equality and political authority. Yet these ceremonies were reserved for gentlemen, leaving others – notably women and Indigenous people – on the political margins.Drink and Democracy traces the development of democratic ideas in New South Wales through the history of public drinking and temperance. As the colony transformed from a convict autocracy to a liberal democracy, Matthew Allen argues, public drinking practices shaped the character of the emerging political order. The ritual of toasting was a symbolic display of restraint – drunkenness without loss of self-control – that embodied the claim to citizenship of white male settlers. Yet the performative sobriety of the temperance movement was also democratic, a display of respectability that politicized its supporters around a rival vision of responsible citizenship. Drink was a way to police the limits of the political realm. The stigma of female drunkenness worked to exclude women from the public sphere, while perceptions of heavy drinking among Aboriginal people cast them as lacking self-control and hence unworthy of political rights.Drink and Democracy reveals that long before the introduction of the franchise, colonists in Australia imagined themselves as citizens. Yet even as democracy expanded, drink marked its limits.